Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oxaliplatin for recurrent metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Prologue Research International | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED